Kerecis is a developer of patent-pending MariGen(TM), an omega3 fish-skin acellular dermal matrix transplantation technology. read more
Kerecis CEO & Leadership Team Ratings
Gudmundur Sigurjonsson and the Kerecis leadership team are scored a F by 19 employees placing it in the Bottom 5% of companies sized 11-50 Employees. The Leadership score includes details about how employees evaluate their executive team, CEO and manager.
Based on 49 ratings, the Leadership score of 28/100 combines employee feedback on their CEO (29/100), Manager (35/100), and Executive Team (25/100).
Gudmundur Sigurjonsson Kerecis CEO Rating
Bottom 5% Compared to other companies of similar sizeF
29 / 100
Gudmundur Sigurjonsson the CEO of Kerecis received an average score of 29 from Kerecis employees.Kerecis Manager Rating
Bottom 5% Compared to other companies of similar sizeF
35 / 100
Kerecis Executive Team Rating
Bottom 5% Compared to other companies of similar sizeF
25 / 100
×